Home
ADAR1 Capital Management reported a 5.3% stake in Rein Therapeutics RNTX · 4,500,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.3%
- Last report
- First report
- Shares held
- 4,500,000 sh
- Class
- Common Stock, $0.001 par value per share
- Holder
- ADAR1 Capital Management
- Event date
- 26/06/30
- Filed
- 26/08/14
First 5%+ report · 5.3% stake
Rein Therapeutics trades, last 26 weeks
What else happened in Rein Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30ADAR1 Capital Management's other 5% stake reports
- ADAR1 Capital Management
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
14% stake
5,257,389 sh
14% stake
Filed 09/08
- ADAR1 Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
15.8% stake
722,419 sh
15.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
8.8% stake
59,000 sh
8.8% stake
Filed 08/14
- ADAR1 Capital Management
5% stakeResearch Alliance Corp III
5% stakeResearch Alliance Corp III
RACC
8.4% stake
650,000 sh
8.4% stake
Filed 08/14
- ADAR1 Capital Management
5% stakePliant Therapeutics
5% stakePliant Therapeutics
PLRX
8.9% stake
5,509,724 sh
8.9% stake
Filed 08/14
